'Total drug costs' presentation slideshows

Bariatric surgery : the psychiatric perspective

Bariatric surgery : the psychiatric perspective. Vineka Heeramun, MD june 2014 PGY3 MedPsych. disclosures. Nil. Case scenario.

1.08k views • 51 slides

Road Ahead for Social Security & Medicare

681 views • 45 slides

MEDICARE PART D Where Do We Stand? Where Are We Going?

MEDICARE PART D Where Do We Stand? Where Are We Going?. Juliette Cubanski, Ph.D. The Henry J. Kaiser Family Foundation Medicare Policy Project - www.kff.org/medicare Families USA Health Action 2007 Washington, D.C. 25 January 2007. Exhibit 1. Overview.

433 views • 34 slides

Selected Demographic Characteristics of Medicare Beneficiaries, 2010

Selected Demographic Characteristics of Medicare Beneficiaries, 2010. Other 5%. 85+ 13%. Hispanic 9%. Black 10%. Male 45%. 75-84 27%. White 77%. 65-74 44%. Female 55%. <65 16%.

443 views • 31 slides

Medicare Prescription Drug Discount Card

Medicare Prescription Drug Discount Card. Ranjani Varadarajan PYPC 7810. Medicare Today. 41 million beneficiaries growing to over 62 million in 2020 $284 billion in expenditures growing to $898 billion in 2020 Slow to adapt to modern medicine Need for supplemental coverage.

553 views • 30 slides

Medicare Prescription Drug Program and Using Part D Data for Research

Medicare Prescription Drug Program and Using Part D Data for Research. Becky Briesacher, PhD Associate Professor, Medicine Division of Geriatric Medicine. Funding and COI.

355 views • 25 slides

Medicare Prescription Drug Program and Using Part D Data for Research

Medicare Prescription Drug Program and Using Part D Data for Research. Becky Briesacher, PhD Associate Professor, Medicine Division of Geriatric Medicine. Funding and COI.

321 views • 25 slides

The Evolving Role of States in the Medicare Drug Benefit Thomas M. Snedden, Director Pennsylvania PACE Program T

The Evolving Role of States in the Medicare Drug Benefit Thomas M. Snedden, Director Pennsylvania PACE Program The Third National Medicare Congress October 16, 2006 Washington, DC. Evolutionary Challenges for PACE

303 views • 17 slides

Medicare Rx Drug Benefit

Medicare Rx Drug Benefit. David Moskowitz, R.Ph, MBA. Senior Healthcare Analyst. Disclaimer. Friedman, Billings, Ramsey Inc. conducts equity research on Astra Zeneca Plc. (AZN), Bristol Meyers Squibb (BMY), Merck (MRK), Pfizer (PFE), Wyeth (WYE), Schering-Plough (SGP) and Eli Lilly (LLY).

265 views • 12 slides

Commonwealth Connector Pharmacy Benefits

Commonwealth Connector Pharmacy Benefits. July 12, 2007. Prescription Drug Coverage. Prescription drugs are an integral component of treatment for many acute and most chronic conditions

248 views • 12 slides

Standard Medicare Prescription Drug Benefit, 2013

Standard Medicare Prescription Drug Benefit, 2013. CATASTROPHIC COVERAGE. Catastrophic Coverage Limit = $6,955 in Estimated Total Drug Costs. Enrollee pays 5%. Plan pays 15 %; Medicare pays 80%. Brand-name drugs Enrollee pays 47.5%; Plan pays 2.5% 50% manufacturer discount

89 views • 1 slides

Standard Medicare Prescription Drug Benefit, 2013

Standard Medicare Prescription Drug Benefit, 2013. CATASTROPHIC COVERAGE. Catastrophic Coverage Limit = $6,733.75* in Estimated Total Drug Costs. Enrollee pays 5%. Plan pays 15 %; Medicare pays 80%. Brand-name drugs Enrollee pays 47.5%; Plan pays 2.5% 50% manufacturer discount

102 views • 1 slides